Stephen Rayport is a Psychiatry physician.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1051 Riverside Dr Unit 62
New York, NY 100321007
Telephone
646-774-7515Provider last certified this registry record 26 Apr 2026.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Benzodiazepine23.5%Clonazepam43%Alprazolam35%Lorazepam15%Diazepam7%Part D<11 patientsAtypical Antipsychotic17.5%Quetiapine Fumarate59%Risperidone14%Aripiprazole13%Olanzapine7%Rexulti6%Part D<11 patients+ 15 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
12 NIH research awards on record, funded 1988–2026 per NIH RePORTER. The latest:
- Synaptic Actions of Amphetamine in the Striatum
New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
FY2026$552,629R01DA056584 - Synaptic Actions of Amphetamine in the Striatum
New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
FY2025$550,811R01DA056584 - Synaptic Actions of Amphetamine in the Striatum
New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
FY2024$548,896R01DA056584
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”